ENDO: GLP-1 receptor agonists tied to higher hypotension risk in patients on BP meds

MedicalXpress | juin 15, 2026

Among patients with preexisting hypertension taking antihypertensive medications, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with an increase in hypotensive-related events, according to a study presented at ENDO 2026, the annual meeting of the Endocrine Society, held from June 13 to 16 in Chicago.